105 related articles for article (PubMed ID: 10535743)
1. Isolation and characterization of a thymidylate synthase-deficient human colon tumor cell line.
Hoganson DK; Williams AW; Berger SH
Biochem Pharmacol; 1999 Nov; 58(10):1529-37. PubMed ID: 10535743
[TBL] [Abstract][Full Text] [Related]
2. A hydroxyl group at residue 216 is essential for catalysis by human thymidylate synthase.
Williams AW; Dunlap RB; Berger SH
Biochemistry; 1998 May; 37(20):7096-102. PubMed ID: 9585520
[TBL] [Abstract][Full Text] [Related]
3. Mutants of human colon adenocarcinoma, selected for thymidylate synthase deficiency.
Houghton PJ; Germain GS; Hazelton BJ; Pennington JW; Houghton JA
Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1377-81. PubMed ID: 2537495
[TBL] [Abstract][Full Text] [Related]
4. Genetic complementation and resistance to 5-fluoro-2'-deoxyuridine in thymidine auxotrophs expressing a highly defective mutant of human thymidylate synthase.
Zapf JW; Zhao PS; Steadman DJ; Berger SH
Biochem Pharmacol; 1999 Sep; 58(6):973-81. PubMed ID: 10509749
[TBL] [Abstract][Full Text] [Related]
5. Mutation(s) of the thymidylate synthase gene of human adenocarcinoma cells causes a thymidylate synthase-negative phenotype that can be attenuated by exogenous folates.
Houghton PJ; Rahman A; Will CL; Dolnick BJ; Houghton JA
Cancer Res; 1992 Feb; 52(3):558-65. PubMed ID: 1732043
[TBL] [Abstract][Full Text] [Related]
6. Multi-level gene expression profiles affected by thymidylate synthase and 5-fluorouracil in colon cancer.
Xi Y; Nakajima G; Schmitz JC; Chu E; Ju J
BMC Genomics; 2006 Apr; 7():68. PubMed ID: 16584549
[TBL] [Abstract][Full Text] [Related]
7. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.
van Triest B; Pinedo HM; van Hensbergen Y; Smid K; Telleman F; Schoenmakers PS; van der Wilt CL; van Laar JA; Noordhuis P; Jansen G; Peters GJ
Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718
[TBL] [Abstract][Full Text] [Related]
8. Functional effects of a naturally occurring amino acid substitution in human thymidylate synthase.
Hughey CT; Barbour KW; Berger FG; Berger SH
Mol Pharmacol; 1993 Aug; 44(2):316-23. PubMed ID: 8355668
[TBL] [Abstract][Full Text] [Related]
9. Thymidylate synthase as a determinant of 5-fluoro-2'-deoxyuridine response in human colonic tumor cell lines.
Berger SH; Berger FG
Mol Pharmacol; 1988 Oct; 34(4):474-9. PubMed ID: 2971871
[TBL] [Abstract][Full Text] [Related]
10. A naturally occurring variation in thymidylate synthase structure is associated with a reduced response to 5-fluoro-2'-deoxyuridine in a human colon tumor cell line.
Berger SH; Barbour KW; Berger FG
Mol Pharmacol; 1988 Oct; 34(4):480-4. PubMed ID: 2971872
[TBL] [Abstract][Full Text] [Related]
11. Subunit complementation of thymidylate synthase in Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase.
Chanama M; Chitnumsub P; Yuthavong Y
Mol Biochem Parasitol; 2005 Jan; 139(1):83-90. PubMed ID: 15610822
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation in thymidylate synthase confers resistance to 5-fluorodeoxyuridine.
Hughey CT; Barbour KW; Berger FG; Berger SH
Adv Exp Med Biol; 1993; 339():67-76. PubMed ID: 8178730
[TBL] [Abstract][Full Text] [Related]
13. Thymidylate synthase-deficient Chinese hamster cells: a selection system for human chromosome 18 and experimental system for the study of thymidylate synthase regulation and fragile X expression.
Nussbaum RL; Walmsley RM; Lesko JG; Airhart SD; Ledbetter DH
Am J Hum Genet; 1985 Nov; 37(6):1192-205. PubMed ID: 3002173
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of a human ileocecal carcinoma cell line (HCT-8) subclone resistant to fluorodeoxyuridine.
Zhang ZG; Malmberg M; Yin MB; Slocum HK; Rustum YM
Biochem Pharmacol; 1993 Mar; 45(5):1157-64. PubMed ID: 8461045
[TBL] [Abstract][Full Text] [Related]
15. Tolerance of 5-fluorodeoxyuridine resistant human thymidylate synthases to alterations in active site residues.
Landis DM; Gerlach JL; Adman ET; Loeb LA
Nucleic Acids Res; 1999 Sep; 27(18):3702-11. PubMed ID: 10471740
[TBL] [Abstract][Full Text] [Related]
16. Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines.
Chu E; Drake JC; Koeller DM; Zinn S; Jamis-Dow CA; Yeh GC; Allegra CJ
Mol Pharmacol; 1991 Feb; 39(2):136-43. PubMed ID: 1704999
[TBL] [Abstract][Full Text] [Related]
17. Thymidylate synthase gene amplification in human colon cancer cell lines resistant to 5-fluorouracil.
Copur S; Aiba K; Drake JC; Allegra CJ; Chu E
Biochem Pharmacol; 1995 May; 49(10):1419-26. PubMed ID: 7763285
[TBL] [Abstract][Full Text] [Related]
18. Biphasic binding of 5-fluoro-2'-deoxyuridylate to human thymidylate synthase.
Reilly RT; Barbour KW; Dunlap RB; Berger FG
Mol Pharmacol; 1995 Jul; 48(1):72-9. PubMed ID: 7623777
[TBL] [Abstract][Full Text] [Related]
19. Modulation of 5-fluoro-2'-deoxyuridine response by folinic acid in human colonic tumor cell lines: the role of thymidylate synthase.
Davis ST; Berger SH
Mol Pharmacol; 1989 Apr; 35(4):422-7. PubMed ID: 2523018
[TBL] [Abstract][Full Text] [Related]
20. Mutants of Chinese hamster cells deficient in thymidylate synthetase.
Li IC; Chu EH
J Cell Physiol; 1984 Aug; 120(2):109-16. PubMed ID: 6611339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
